William C. Miller

William C. Miller

Auto-generated profile, based on publicly available information

William C. Miller

Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, USA

Research Focus & Metrics

Academic Career Length

70Years (1957-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2004 in JAMA
Verified
Journal Article
Closed access
PDF file
WMWilliam C. Miller
William C. Miller
CFCarol A. Ford
Carol A. Ford
MMMartina Morris
Martina Morris
MHMark S. Handcock
Mark S. Handcock
JSJohn L. Schmitz
John L. Schmitz
JUJ. Richard Udry
J. Richard Udry
Research from JAMA — Prevalence of Chlamydial and Gonococcal Infections Among Young Adults in the United States — ContextChlamydial and gonococcal infections are important causes of pelvic inflammatory disease, ectopic pregnancy, and infertility. Although screening for Chlamydia trachomatis is widely recommended among young adult women, little information is available regarding the prevalence of chlamydial and gonococcal infections in the general young adult population.ObjectiveTo determine the prevalence of chlamydial and gonoccoccal infections in a nationally representative sample of young adults living in the United States.Design, Setting, and ParticipantsCross-sectional analyses of a prospective cohort study of a nationally representative sample of 14 322 young adults aged 18 to 26 years. In-home interviews were conducted across the United States for Wave III of The National Longitudinal Study of Adolescent Health (Add Health) from April 2, 2001, to May 9, 2002. This study sample represented 66.3% of the original 18 924 participants in Wave I of Add Health. First-void urine specimens using ligase chain reaction assay were available for 12 548 (87.6%) of the Wave III participants.Main Outcome MeasuresPrevalences of chlamydial and gonococcal infections in the general young adult population, and by age, self-reported race/ethnicity, and geographic region of current residence.ResultsOverall prevalence of chlamydial infection was 4.19% (95% confidence interval [CI], 3.48%-4.90%). Women (4.74%; 95% CI, 3.93%-5.71%) were more likely to be infected than men (3.67%; 95% CI, 2.93%-4.58%; prevalence ratio, 1.29; 95% CI, 1.03-1.63). The prevalence of chlamydial infection was highest among black women (13.95%; 95% CI, 11.25%-17.18%) and black men (11.12%; 95% CI, 8.51%-14.42%); lowest prevalences were among Asian men (1.14%; 95% CI, 0.40%-3.21%), white men (1.38%; 95% CI, 0.93%-2.03%), and white women (2.52%; 95% CI, 1.90%-3.34%). Prevalence of chlamydial infection was highest in the south (5.39%; 95% CI, 4.24%-6.83%) and lowest in the northeast (2.39%; 95% CI, 1.56%-3.65%). Overall prevalence of gonorrhea was 0.43% (95% CI, 0.29%-0.63%). Among black men and women, the prevalence was 2.13% (95% CI, 1.46%-3.10%) and among white young adults, 0.10% (95% CI, 0.03%-0.27%). Prevalence of coinfection with both chlamydial and gonococcal infections was 0.030% (95% CI, 0.18%-0.49%).ConclusionsThe prevalence of chlamydial infection is high among young adults in the United States. Substantial racial/ethnic disparities are present in the prevalence of both chlamydial and gonococcal infections.

15 April 2005 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
CKChristine E. Kaestle
Christine E. Kaestle
CHCarolyn T. Halpern
Carolyn T. Halpern
WMWilliam C. Miller
William C. Miller
CFCarol A. Ford
Carol A. Ford
The authors examined the relation between age at first vaginal intercourse and a positive nucleic acid amplification test for sexually transmitted infection (STI). A nationally representative sample of 9,844 respondents aged 18–26 years was tested for chlamydial infection, gonorrhea, and trichomoniasis in wave 3 (2001–2002) of the National Longitudinal Study of Adolescent Health. The authors used multiple logistic regression to assess the relation between age at first sexual intercourse and these STIs and to examine variation by current age, sex, race, and ethnicity. Younger ages at first intercourse were associated with higher odds of STI in comparison with older ages, but the effect diminished with increasing current age. For example, the odds of having an STI for an 18-year-old who first had intercourse at age 13 were more than twice those of an 18-year-old who first had intercourse at age 17 (prevalence odds ratio = 2.25, 95% confidence interval: 1.42, 3.59). In contrast, the odds of having an STI among 24-year-olds with first intercourse at age 13 versus those with first intercourse at age 17 were the same (prevalence odds ratio = 1.11, 95% confidence interval: 0.88, 1.39). Thus, earlier initiation of sexual intercourse is strongly associated with STIs for older adolescents but not for young adults over age 23 years.

1 July 2011 in The Lancet
Verified
Journal Article
Closed access
KPKimberly A Powers
Kimberly A Powers
AGAzra C Ghani
Azra C Ghani
WMWilliam C Miller
William C Miller
IHIrving F Hoffman
Irving F Hoffman
APAudrey E Pettifor
Audrey E Pettifor
MCMyron S Cohen
Myron S Cohen

5 May 2005 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
CPChristopher D. Pilcher
Christopher D. Pilcher
SFSusan A. Fiscus
Susan A. Fiscus
TNTrang Q. Nguyen
Trang Q. Nguyen
EFEvelyn Foust
Evelyn Foust
LWLeslie Wolf
Leslie Wolf
PLPeter A. Leone
Peter A. Leone
North Carolina has added nucleic acid amplification testing for the human immunodeficiency virus (HIV) to standard HIV antibody tests to detect persons with acute HIV infection who are viremic but antibody-negative.

1 January 2007 in American Journal of Public Health
Verified
Journal Article
Closed access
DHDenise Dion Hallfors
Denise Dion Hallfors
BIBonita J. Iritani
Bonita J. Iritani
WMWilliam C. Miller
William C. Miller
DBDaniel J. Bauer
Daniel J. Bauer
Objectives. We used nationally representative data to examine whether individuals’ sexual and drug behavior patterns account for racial disparities in sexually transmitted disease (STD) and HIV prevalence. Methods. Data were derived from wave III of the National Longitudinal Study of Adolescent Health. Participants were aged 18 to 26 years old; analyses were limited to non-Hispanic Blacks and Whites. Theory and cluster analyses yielded 16 unique behavior patterns. Bivariate analyses compared STD and HIV prevalences for each behavior pattern, by race. Logistic regression analyses examined within-pattern race effects before and after control for covariates. Results. Unadjusted odds of STD and HIV infection were significantly higher among Blacks than among Whites for 11 of the risk behavior patterns assessed. Across behavior patterns, covariates had little effect on reducing race odds ratios. Conclusions. White young adults in the United States are at elevated STD and HIV risk when they engage in high-risk behaviors. Black young adults, however, are at high risk even when their behaviors are normative. Factors other than individual risk behaviors and covariates appear to account for racial disparities, indicating the need for population-level interventions.

1 October 2002 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
SMStephanie A. Mulherin
Stephanie A. Mulherin
WMWilliam C. Miller
William C. Miller
Diagnostic tests must be evaluated in a clinically relevant population. However, test performance often varies across population subgroups. Spectrum bias, a term commonly used to describe this heterogeneity, is typically thought to occur when diagnostic test performance varies across patient subgroups and a study of that test's performance does not adequately represent all subgroups. Yet subgroup variation is not a bias if appropriate analyses are conducted. Failure to recognize and address heterogeneity will lead to estimates of test performance that are not generalizable to the relevant clinical populations. Heterogeneity can be addressed with relatively simple stratification procedures, limited primarily by the sample size and the precision of the estimates. This paper proposes the use of the term spectrum effect, rather than spectrum bias, and outlines strategies for using stratified sensitivity and specificity estimates, likelihood ratios, and receiver-operating characteristic curves. Investigators of diagnostic tests should consider the potential for spectrum effect seriously and should address heterogeneity in their analyses. Furthermore, clinicians should consider study samples carefully to determine whether results are generalizable to their specific patient population.